← Leaderboards
Anna Waclawa Sromek
Mclean Hospital
$723,551
Attributed
$723,551
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $260.5K · FY2014–20$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$723,551 · 2
By mechanism
R21$506,917 · 1
U18$216,634 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineCorpus Striatum StructureProteinsDoseAgonistAnimalsIn VivoLigandsAffinityCellsFutureDopamine D2 ReceptorBrainAnalogBehavior DisordersInterestBaseImageIn VitroAutoradiographyBrain DiseasesEvaluationCharacteristicsBiodistribution
Grant awards (4)
New Therapeutics for Treating Cocaine Addiction Targeting D1-D2 Heteromers$119,767
U18 · FY2020 · DA · contact PI
New Therapeutics for Treating Cocaine Addiction Targeting D1-D2 Heteromers$96,867
U18 · FY2020 · DA · contact PI
F_18 Labeled D2 Agonist Ligands for PET Imaging of Dopaminergic Dysfunction$246,459
R21 · FY2015 · MH · contact PI
F_18 Labeled D2 Agonist Ligands for PET Imaging of Dopaminergic Dysfunction$260,458
R21 · FY2014 · MH · contact PI